Consistent CBD pathways include the upregulation of the “metabolic pathway” across 17 studies (Fig. 6B) and the “cellular response to zinc ion” pathway across nine studies (consistent with the reproducibility of DEGs SLC30A1 and MT2A), and the downregulation of cell cycle, mRNA export, cancer, and mismatch repair pathways (Fig. 6C). The gene discussed is SLC30A1; the disease is cancer.